
HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Stock analysts at HC Wainwright reduced their FY2027 EPS estimates for HIVE Blockchain Technologies in a research note issued to investors on Wednesday, November 11th. HC Wainwright analyst M. Colonnese now anticipates that the company will post earnings of ($0.84) per share for the year, down from their prior estimate of ($0.70).
Separately, Chardan Capital upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Monday, July 27th. Two analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, HIVE Blockchain Technologies currently has an average rating of “Buy”.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
Read More
- Five stocks we like better than HIVE Blockchain Technologies
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
